Patent · US Active

Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers

US9321808B2 · kind B2 · utility

22Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 20, 2012
Grant dateApr 26, 2016
Priority date
Expiry dateFeb 20, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to conformationally constrained homo- and heterodimeric mimetics of Smac with function as inhibitors of Inhibitor of Apoptosis Proteins (IAPs), the invention also relates to the use of these compounds in therapy, wherein the induction of apoptotic cell death is beneficial, especially in the treatment of cancer, alone or in combination with other active ingredients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.